Grifols Class A/€GRF
05:30
09:10
12:45
16:25
20:00
1D1W1MYTD1Y5YMAX
About Grifols Class A
Grifols SA, operating under the ticker GRF, is a biopharmaceutical company specialized in the production of plasma-derived medicines. Founded in 1940 and headquartered in Barcelona, Spain, Grifols is engaged in the diagnosis, prevention, and treatment of a variety of diseases, with a strong focus on immunology, hematology, and intensive care sectors. The company operates globally, leveraging advanced technologies and rigorous quality processes to provide essential medical products.
Ticker
€GRF
Sector
Primary listing
BME
Industry
Biotechnology
Headquarters
Employees
23,800
ISIN
ES0171996087
Website
Grifols Class A Metrics
BasicAdvanced
€7B
40.66
€0.29
1.01
-
Price and volume
Market cap
€7B
Beta
1.01
52-week high
€11.78
52-week low
€7.32
Average daily volume
1.9M
Financial strength
Current ratio
2.599
Quick ratio
0.942
Long term debt to equity
113.214
Total debt to equity
121.139
Dividend payout ratio (TTM)
0.49%
Interest coverage (TTM)
2.29%
Profitability
EBITDA (TTM)
1,665.704
Gross margin (TTM)
39.39%
Net profit margin (TTM)
2.65%
Operating margin (TTM)
18.59%
Effective tax rate (TTM)
44.76%
Revenue per employee (TTM)
€310,000
Management effectiveness
Return on assets (TTM)
3.99%
Return on equity (TTM)
3.45%
Valuation
Price to earnings (TTM)
40.656
Price to revenue (TTM)
1.074
Price to book
1.25
Price to tangible book (TTM)
-1.26
Price to free cash flow (TTM)
9.85
Free cash flow yield (TTM)
10.15%
Free cash flow per share (TTM)
118.10%
Growth
Revenue change (TTM)
10.76%
3-year revenue growth (CAGR)
13.70%
10-year revenue growth (CAGR)
7.84%
10-year earnings per share growth (CAGR)
-8.57%
What the Analysts think about Grifols Class A
Analyst ratings (Buy, Hold, Sell) for Grifols Class A stock.
Bulls say / Bears say
Grifols reported a 10.2% increase in revenues for 2024, reaching €7.21 billion, surpassing its 7% growth target. (reuters.com)
The company's net profit nearly tripled in the first quarter of 2025, with a 179% year-over-year increase to €60 million, indicating strong financial performance. (reuters.com)
Grifols has set an ambitious goal to achieve €10 billion in revenues by 2029, reflecting confidence in its long-term growth prospects. (cincodias.elpais.com)
The hedge fund Rokos Global Macro Master Fund reduced its stake in Grifols to below 1%, which could signal decreased investor confidence. (cincodias.elpais.com)
A U.S. court allowed Grifols' defamation lawsuit against Gotham City Research to proceed, highlighting ongoing legal challenges that may affect the company's reputation. (reuters.com)
Grifols' shares experienced volatility following Brookfield's withdrawal from acquisition talks due to disagreements over valuation, potentially impacting investor sentiment. (reuters.com)
Data summarised monthly by Lightyear AI. Last updated on 9 Jul 2025.
Grifols Class A Financial Performance
Revenues and expenses
Grifols Class A Earnings Performance
Company profitability
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Grifols Class A stock?
Grifols Class A (GRF) has a market cap of €7B as of July 11, 2025.
What is the P/E ratio for Grifols Class A stock?
The price to earnings (P/E) ratio for Grifols Class A (GRF) stock is 40.66 as of July 11, 2025.
Does Grifols Class A stock pay dividends?
No, Grifols Class A (GRF) stock does not pay dividends to its shareholders as of July 11, 2025.
When is the next Grifols Class A dividend payment date?
Grifols Class A (GRF) stock does not pay dividends to its shareholders.
What is the beta indicator for Grifols Class A?
Grifols Class A (GRF) has a beta rating of 1.01. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.